|Articles|October 1, 2000

October 2000
Volume 6
Issue 10

A Comparison of Medicare Fee-for-Service and a Group-Model HMO in the Inpatient Management and Long-Term Survival of Elderly Individuals with Syncope

Author(s)William S. Getchell, MD, MPH, Greg C. Larsen, MD, Cynthia D. Morris, PhD, MPH

Download PDF: A Comparison of Medicare Fee-for-Service and a Group-Model HMO in the Inpatient Management and Long-Term Survival of Elderly Individuals with Syncope

Articles in this issue

over 25 years ago

Article

Follow-Up Among Women with an Abnormal Mammogram in an HMO: Is It Timely, Complete, and Efficient?

over 25 years ago

Article

Accrediting Organizations and Quality Improvement

over 25 years ago

Article

Efficient Evaluation of Thyroid Nodules by Primary Care Providers and Thyroid Specialists

over 25 years ago

Article

Therapeutic Substitution of Cimetidine for Nizatidine Was Not Associated with an Increase in Healthcare Utilization

over 25 years ago

Article

Diagnosis of Skin Disease by Nondermatologists

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Latest CME

Online Article

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

AJMC Supplement

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

2.0 Credits / Pain Management

A Comparison of Medicare Fee-for-Service and a Group-Model HMO in the Inpatient Management and Long-Term Survival of Elderly Individuals with Syncope

Articles in this issue

Newsletter

Related Content

Quality of Life: The Pending Outcome in Idiopathic Pulmonary Fibrosis

Increased Payments to Medicare Advantage Plans for Dually Eligible Beneficiaries

The Health Information Technology Special Issue: Tracking Expansion Across Settings, Technologies, and Stakeholders

Building Trust: Public Priorities for Health Care AI Labeling

Ambient AI Tool Adoption in US Hospitals and Associated Factors

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

Trending on AJMC

TrumpRx Launch Brings Savings—and Uncertainty

How Do GLP-1 Agonists Fit Into Stroke Care?

Addressing Disparities at Every Step of the Stroke Care Pathway: Luke Messac, MD, PhD

Aligning Treatment Goals in IgA Nephropathy: Applying KDIGO’s Dual-Pathway Framework to Clinical Decision-Making

5 Things to Know About the Oral GLP-1 Era